| Trial ID: | L2013 |
| Source ID: | NCT00551876
|
| Associated Drug: |
Mk0653, Ezetimibe / Duration Of Treatment: 30 Weeks
|
| Title: |
Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: MK0653, ezetimibe / Duration of Treatment: 30 Weeks|DRUG: Comparator : ezetimibe (+) simvastatin / Duration of Treatment: 30 Weeks
|
| Outcome Measures: |
Primary: Percent change in fasting LDL-C from baseline to the average of the Week 6/Week 12 measurements, 6 & 12 Weeks | Secondary: Well tolerated in patients in Diabetic patients, 30 Weeks
|
| Sponsor/Collaborators: |
Sponsor: Organon and Co
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
214
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2001-12
|
| Completion Date: |
2003-01
|
| Results First Posted: |
|
| Last Update Posted: |
2024-08-15
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00551876
|
